The Multi-Organ Transplant Program, London Health Sciences Centre, London, Ontario, Canada.
Transpl Immunol. 2011 Jan 15;24(2):119-26. doi: 10.1016/j.trim.2010.11.003. Epub 2010 Nov 9.
Regulatory T (Treg) cells play an important role in the regulation of immune responses but whether Treg will induce tolerance in transplant recipients in the clinic remains unknown. Our previous studies have shown that TCRαβ(+)CD3(+)CD4⁻CD8⁻NK1.1⁻ (double negative, DN) T cells suppress T cell responses and prolong allograft survival in a single locus MHC-mismatched mouse model. In this study, we investigated the role of DNT cells in a more robust, fully MHC-mismatched BALB/c to C57BL/6 transplantation model, which may be more clinically relevant. Adoptive transfer of DNT cells in combination with short-term rapamycin treatment (days 1-9) induced long-term heart allograft survival (101±31 vs. 39±13 days rapamycin alone, p<0.01). Furthermore adoptive transfer DNT cells augmented CD4+Foxp3+ Treg cells accumulation in transplant recipients while depletion of CD4(+) Treg cells by anti-CD25 inhibited the effect of DNT cells on long-term graft survival (48±12 days vs. 101±31 days, p<0.001). In conclusion, DNT cells combined with short-term immunosuppression can prolong allograft survival, which may be through the accumulation of CD4(+)Foxp3(+) Treg cells in the recipient. Our result suggests that allograft tolerance may require the co-existence of different type Treg cell phenotypes which are affected by current immunosuppression.
调节性 T(Treg)细胞在调节免疫反应中发挥重要作用,但 Treg 是否会在临床上诱导移植受者的耐受尚不清楚。我们之前的研究表明,TCRαβ(+)CD3(+)CD4(-)CD8(-)NK1.1(-)(双阴性,DN)T 细胞可抑制 T 细胞反应并延长单基因座 MHC 错配小鼠模型中的同种异体移植物存活时间。在这项研究中,我们在更强大的、完全 MHC 错配的 BALB/c 到 C57BL/6 移植模型中研究了 DNT 细胞的作用,这可能更具临床相关性。在短期雷帕霉素治疗(第 1-9 天)的同时过继转移 DNT 细胞可诱导长期心脏同种异体移植物存活(雷帕霉素单独使用 101±31 天 vs. 39±13 天,p<0.01)。此外,过继转移 DNT 细胞可增加移植受者中 CD4+Foxp3+Treg 细胞的积累,而通过抗 CD25 耗竭 CD4(+)Treg 细胞可抑制 DNT 细胞对长期移植物存活的影响(48±12 天 vs. 101±31 天,p<0.001)。总之,DNT 细胞联合短期免疫抑制可延长同种异体移植物的存活时间,这可能是通过受体中 CD4(+)Foxp3(+)Treg 细胞的积累实现的。我们的结果表明,同种异体耐受可能需要不同类型 Treg 细胞表型的共存,而这受当前免疫抑制的影响。